Edition:
United Kingdom

Aptose Biosciences Inc (APTO.OQ)

APTO.OQ on NASDAQ Stock Exchange Capital Market

2.29USD
16 Jan 2019
Change (% chg)

$0.05 (+2.23%)
Prev Close
$2.24
Open
$2.24
Day's High
$2.41
Day's Low
$2.21
Volume
31,926
Avg. Vol
30,734
52-wk High
$4.55
52-wk Low
$1.80

Chart for

About

Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates... (more)

Overall

Beta: 2.10
Market Cap(Mil.): $33.86
Shares Outstanding(Mil.): 24.17
Dividend: --
Yield (%): --

Financials

  APTO.OQ Industry Sector
P/E (TTM): -- 69.71 34.38
EPS (TTM): -0.80 -- --
ROI: -123.77 8.99 14.96
ROE: -123.77 10.13 16.53

Earnings vs. Estimates